ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

Researchers Call For New Approach To Peripheral Neuropathy Testing

February 24, 2012

GM Corp, to Reimburse Marrow Transplants for Breast Cancer

March 15, 1996

In Brief: MDA Treats Only 9% Of Texas Cancer Patients; Clinical Director Search Narrows To Three

March 12, 1976

Anidulafungin Safe And Well-Tolerated In Pediatric Patients With Neutropenia

November 26, 2004

Assurances On Methods For Misconduct Reporting Required

December 1, 1989

Practice of Oncology Must Incorporate Clinical Research, NCI Director Tells ASCO

May 30, 1997